High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$31.9M
$31,929,222
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| BBIO |
BridgeBio Pharma, Inc.
|
CEO
10b5-1 Sell
|
2026-02-19 | $2,002,717Largex3 | S | Form 4 |
| BBIO |
BridgeBio Pharma, Inc.
|
CEO
10b5-1 Sell
|
2026-02-11 | $2,871,087Largex8 | S | Form 4 |
| BBIO |
BridgeBio Pharma, Inc.
|
CEO
10b5-1 Sell
|
2026-02-10 | $2,877,580Largex4 | S | Form 4 |
| BBIO |
BridgeBio Pharma, Inc.
|
CEO
10b5-1 Sell
|
2026-01-09 | $3,084,313Largex8 | S | Form 4 |
| BBIO |
BridgeBio Pharma, Inc.
|
CEO
10b5-1 Sell
|
2026-01-08 | $2,958,855Largex6 | S | Form 4 |
| BBIO |
BridgeBio Pharma, Inc.
|
CEO
10b5-1 Sell
|
2025-12-15 | $2,239,902Largex2 | S | Form 4 |
| BBIO |
BridgeBio Pharma, Inc.
|
CEO
Equity Compensation
|
2025-12-12 | $0 | M | Form 4 |
| BBIO |
BridgeBio Pharma, Inc.
|
CEO
10b5-1 Sell
|
2025-12-05 | $2,932,563Largex4 | S | Form 4 |
| BBIO |
BridgeBio Pharma, Inc.
|
CEO
10b5-1 Sell
|
2025-12-04 | $2,975,913Largex6 | S | Form 4 |
| BBIO |
BridgeBio Pharma, Inc.
|
CEO
10b5-1 Sell
|
2025-11-20 | $1,722,224Largex3 | S | Form 4 |
| BBIO |
BridgeBio Pharma, Inc.
|
CEO
10b5-1 Sell
|
2025-11-07 | $2,456,994Largex6 | S | Form 4 |
| BBIO |
BridgeBio Pharma, Inc.
|
CEO
10b5-1 Sell
|
2025-11-06 | $2,519,678Largex5 | S | Form 4 |
| BBIO |
BridgeBio Pharma, Inc.
|
CEO
10b5-1 Sell
|
2025-10-09 | $1,096,046Large | S | Form 4 |
| BBIO |
BridgeBio Pharma, Inc.
|
CEO
10b5-1 Sell
|
2025-10-08 | $2,191,350Largex4 | S | Form 4 |